Onset of diabetes with high titer anti-GAD antibody after IFN therapy for chronic hepatitis

Diabetes Research and Clinical Practice

Volumn 30, Issue 3, 1995, Pages 237-241

  Shiba, Teruo ^a   Morino, Yoshihiro ^a   Tagawa, Kazumi ^a   Fujino, Hitoshi ^a   Unuma, Tadao ^a  

^a MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Anti GAD antibody; CSII; IFN

Indexed keywords

GLUTAMATE DECARBOXYLASE; INSULIN; INTERFERON; RECOMBINANT ALPHA INTERFERON;

ADULT; ARTICLE; CASE REPORT; FEMALE; HEPATITIS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIVIRAL AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; GLUTAMATE DECARBOXYLASE; HEPATITIS, CHRONIC; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, PARENTERAL; INSULIN; INTERFERON-ALPHA; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 0029552726     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(95)01188-9     Document Type: Article

References (19)

1. Immunology of IDDM (Type I diabetes)-Entering the '90s
2. Increased expression of human monocyte HLA-DR antigen and Fc receptors in response to human interferon in vivo
3. Augumentation by interferon of human natural and antibody dependent cell-mediated cytotoxicity
4. Treatment of chronic type-B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis
5. IFN-γ and tumor necrosis factor Cytotoxicity to murine islet of Langerhans
6. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus
7. Induction of type I diabetes by interferon-α in transgenic mice
8. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
9. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes
10. Development of type 1 diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis
11. Type I diabetes mellitus—A chronic autoimmune disease
12. Effect of interferon on glucose tolerance and insulin sensitivity
13. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD 65) shows that 64K autoantibody positivity at onset predicts diabetes type
14. Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon α-2a
15. A case of insulin-dependent diabetes mellitus (IDDM) following interferon-α therapy for type C chronic hepatitis
16. Occurrence of IDDM during interferon therapy for chronic viral hepatitis
17. A case of NIDDM with transition to IDDM by interferon administration for the treatment of chronic hepatitis C
18. Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia
19. A case of insulin-dependent diabetes mellitus developing during interferon therapy for chronic hepatitis type C